Lucintel Forecasts The Global Structural Heart Device Market To Reach $13 Billion By 2030

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to a market report by Lucintel, the future of the global structural heart device market looks promising with opportunities in public and private hospitals. The global structural heart device market is expected to reach an estimated $13 billion by 2030 from $8 billion in 2023 at a CAGR of 8% from 2023 to 2030. The major drivers for this market are growing demand for minimally invasive surgery, growing healthcare expenditure, and a growing geriatric population.
A total of less than 200 pages report to understand trends, opportunity and forecast in structural heart device market to 2030 by procedure, which includes repair (annuloplasty, valvuloplasty, transcatheter mitral valve repair, and other repairs) and replacement (surgical valves, mechanical heart valves, tissue heart valves, and transcatheter aortic valves), position (aorta, mitral, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that the TAVR, TMVR, and tissue heart valve segments in structural heart device market are expected to show above average growth during the forecast period.
Within ...
... the global structural heart device market, the TAVR segment is expected to remain the largest segment. Increased catheter based procedures coupled with rising adoption of technological advancements in an effort to reduce treatment duration for high conventional surgical risk patients is expected to result in significant growth of the transcatheter aortic valve replacement market.
Download sample by clicking on structural heart device market
North America is expected to remain the largest market and is expected to witness the highest growth rate during the forecast period mainly due to increasing adoption of minimally invasive procedures for heart valve repair and replacement in this region.
Edwards Lifesciences Corporation, Medtronic Public Limited Company, Abbott Laboratories, Medtronic Public Limited Company, LivaNova PLC are the major suppliers in the structural heart device market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Cast Polypropylene Film For Packaging Market
Chassis Module Market
Four-Loop FIBC Market
High Temperature Overhead Conductor Market
Marine and Port Construction Market
X-Ray Scintillator Market